At GoBroad Healthcare Group, we believe that "The Needs of The Patient Come First." This philosophy drives our commitment to pioneering the field of tumor therapy. Whether it's lung cancer, pancreatic cancer, digestive tract cancer, or other complex tumor types, we are actively engaged in innovative treatments and technologies. Our hospital has become a beacon of hope for many, embodying a holistic approach to patient care, cutting-edge research, and the application of advanced therapies.

Leading the Way with Cellular and Targeted Therapies

One of the cornerstones of our approach to tumor therapy is the integration of cellular transplant therapy and cell-targeted treatments. We have a distinguished team of both domestic and international experts, whose combined expertise allows us to offer some of the most advanced therapies available today. For instance, our pioneering work in cell-targeted therapy for pancreatic cancer has positioned us as innovators in the fight against this difficult-to-treat disease. In addition, we are making significant strides in lung cancer and digestive tract cancer, where we apply cutting-edge techniques like CAR-T-cell therapy and precision targeted therapies to personalize care and improve outcomes.

As a hospital committed to the highest standards of clinical care, we offer not only medical treatment but also comprehensive services in clinical research, diagnostics, and a dedicated cancer multidisciplinary team. This holistic, research-driven model ensures that our patients receive the most effective, scientifically proven therapies. Through these efforts, we are working tirelessly to make GoBroad one of the best lung cancer hospitals and best breast cancer hospitals in the world. Our constant collaboration with leading experts ensures that our patients receive access to the latest advances in tumor therapy and the best possible outcomes.

Research, Innovation, and a Vision for the Future

In addition to our direct patient care efforts, GoBroad is a research hub focused on transforming the medical field. We aim to improve the diagnosis and treatment of complex cancers through clinical research and the industrialization of biomedicine and medical devices. Our mission is to create a research-driven hospital that meets the innovative demands of China's biomedical industry while adhering to international standards. We are working toward an ecosystem where medical research and clinical application go hand-in-hand, allowing us to make real-time, evidence-based decisions that improve patient care.

To enhance medical efficiency and optimize the patient experience, we have introduced a direct payment system that integrates both medical and commercial insurance. By aligning our services with international healthcare standards, we are providing patients with a dual-track, high-quality care experience. This approach makes accessing world-class tumor therapy easier and more affordable for those who need it most.

Multidisciplinary Collaboration for Better Outcomes

At GoBroad, we recognize that treating complex tumors requires more than just a single discipline. It requires the collaboration of various medical specialties working together seamlessly. For example, the treatment of neuroendocrine tumors involves a unique multidisciplinary team of internal and external medicine specialists, radiology, pathology, and oncology experts, including some of the leading nuclear medicine specialists in the country. This collaborative approach has been refined over the years, and it has proven to significantly improve the effectiveness and efficiency of our treatment plans.

As a result, GoBroad is at the forefront of nuclear medicine treatments, particularly in the area of radiopharmaceuticals. We have become one of the first institutions in China to explore nuclear drug treatments for neuroendocrine tumors, contributing to the rapid development of nuclear medicine in the country. By advancing tumor therapy with nuclear drugs and other innovative treatments, we continue to push the boundaries of what is possible in cancer care.

Conclusion

At GoBroad Healthcare Group, we are more than just a hospital—we are a hub for transformation in the field of tumor therapy. From our commitment to patient-centered care to our groundbreaking research and multidisciplinary approach, we are setting new standards in cancer treatment. With every breakthrough, every patient, and every new development, we strive to provide the best possible care to our patients and continue our mission to be an innovator in the fight against cancer. Our promise is to deliver not only cutting-edge treatments but also compassion, research-driven care, and a relentless pursuit of better outcomes.